the carbon nanotube solution for the global medical market
BioPact is a medical nano-technology development company. BioPact’s Medical Grade MOLECULAR REBAR®(MGMR®), is a unique composition of matter derived from carbon nanotubes. MGMR are discrete (individual), free of impurities, open-ended, length controlled and surface functionalized carbon nanotubes. The unique physical and chemical properties of these tubes overcome the limitations of traditional dirty, tangled carbon nanotube bundles. Drugs or other substances may be loaded inside the hollow tubes or bonded to the exterior. The tubes themselves may be sensitized, and thus used as a therapeutic.
MGMR is applicable in drug delivery and gene therapy programs. The technology can be applied to developing a new product, resurrecting a struggling development program or improving/extending the protected life of marketed products.
By utilizing MGMR, drug developers can resolve challenges such as controlled-release, targeted delivery, toxicity and instability, to name a few.
BioPact's safety and efficacy data supports immediate collaborations with large and small molecule drug developers with stability, toxicity and targeting challenges in oncologic indications such as liver cancer, bone cancer, lymphoma and multiple myeloma.